Ketamine’s promising potential to ease depression is one of the reasons why its use has recently skyrocketed in the US and ...

We’re used to hearing that depression is a chemical problem, one that starts in the brain and can only be fixed with ...

In zebrafish, ketamine causes changes a brain circuit involved in "giving up." That may help explain how the drug helps ...

Those on the extreme end of the depression spectrum face symptoms that impact their daily activities too and not just their ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

Neumora Therapeutics ( NMRA) shares crashed 80% to an all-time low Thursday when the biopharmaceutical firm announced that a ...

Neumora Therapeutics, Inc. (NASDAQ:NMRA) stock traded lower after the company released data from the Phase 3 KOASTAL-1 Study ...

Life has many ups and downs, and it's normal to feel the lows from time to time. However, for some people, this sadness may ...

Jan 2 (Reuters) - Neumora Therapeutics' (NMRA.O), opens new tab shares tumbled more than 80% on Thursday after its experimental depression drug failed to reduce symptoms such as sadness and ...

In a highly anticipated readout for the kappa opioid receptor class in major depressive disorder, Neumora’s navacaprant ...

Depression is a common mental health condition and mood disorder that causes a persistent feeling of sadness and loss of ...